Description
Product form
tablets.
Packing
60 pcs.
Pharmacological action
Dibicor has a metabolic, cardiotropic, hypoglycemic effect.
Indications
cardiovascular failure of various etiologies
intoxication caused by cardiac glycosides
type 1 diabetes mellitus
type 2 diabetes mellitus, incl. with moderate hypercholesterolemia.
Contraindications
hypersensitivity to the drug
age up to 18 years (efficacy and safety have not been established).
Special instructions
While taking Dibicorum, the dose of cardiac glycosides should sometimes be reduced by 2 times, depending on the sensitivity of patients to cardiac glycosides.
The same rule applies to slow calcium channel blockers.
Composition
Active ingredient:
taurine 250 mg
excipients:
MCC – 23 mg
potato starch – 18 mg
gelatin – 6 mg
silicon dioxide colloidal dioxide (Aerosil) – 0.3 mg
calcium stearate – 2.7 mg
Dosage and administration of
Dibicor taken orally, 20 minutes before meals.
With heart failure – 250-500 mg 2 times a day, the course of treatment – 30 days.
Dose may be increased to 2-3 g / day or reduced to 125 mg per dose.
In case of type 2 diabetes mellitus – 500 mg 2 times a day as monotherapy or in combination with sugar-lowering tablets.
In type 1 diabetes, 500 mg 2 times a day in combination with insulin therapy for 3-6 months.
Side effects
Allergic reactions to the components of the drug Dibicor are possible.
Drug Interactions
Dibicor may be used with other drugs to enhance the inotropic effect of cardiac glycosides.
Storage conditions
In a dry, dark place at a temperature of no higher than 25 ° C.
Deystvuyuschee substances
Taurine
Conditions of release from drugstores
Without prescription
dosage form
tablets
Pik-Pharma, Russia
